🔎 Trials Near Me

Home › Sakit sa Coronary Artery

Pag-aaral pangklinika para sa Sakit sa Coronary Artery na nagre-recruit sa U.S.

66 pag-aaral para sa Sakit sa Coronary Artery ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.

Mga lungsod na may pinakamaraming pag-aaral

Ayos sa estado

Mga pag-aaral na kamakailan lamang in-update

Opisyal na teksto ng pag-aaral (English)

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07258290

The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI

Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07479433

A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease

Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07839936

PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

Nagre-recruit
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06445608

The Bridging Antiplatelet Therapy With Cangrelor 2 Study

Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07225842

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07521007

Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma

Nagre-recruit
Edad 55 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07704918

Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

Nagre-recruit
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07296744

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 99 · Kalalakihan · Na-update Okt 30, 2026 · NCT05611307

Lifewise Preventive Video Education in Primary Care

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06730737

Virtue® SAB in the Treatment of Coronary ISR Trial

Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07045194

Prevail Global Study

Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06535854

Product Surveillance Registry

Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT01524276

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT05427370

Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP

Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT07830719

Prevent Cardiac Surgery Associated AKI Trial

Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT06620523

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

Nagre-recruit
Edad 40 pataas · Kalalakihan · Na-update Okt 5, 2026 · NCT05879913

ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07559903

IVUS CHIP UPP Registry

Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06625801

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05485961

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.